Patent Yard Sign in
Canadian application, no grantCanada

Methods and compositions for genetically modifying primate bone marrow cells

CA 2283641 A1 · Owner: Valerio, Domenico · Inventors: Van Beusechem, Victor Willem; Valerio, Domenico

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A method is provided for genetically modifying primate bone marrow cells comprising isolating bone marrow cells from a primate and by means of , cocultivation, exposing the isolated bone marrow cells to cells that produce a recombinant amphotropic retrovirus with a genome based on a retroviral vector that contains the genetic information to be introduced into the bone marrow cells. Recombinant amphotropic retrovirus-producing cells suitable for use in , this method also are provided as genetically modified primate bone marrow cells with the capacity for regeneration in vivo.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 17, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 17, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledMarch 17, 1998
GrantedNo grant recorded
Term endedMarch 17, 2018
Patent numberCA 2283641 A1
Classification (IPC)C12N15/86 +2 more

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedMarch 17, 1998Term endedMarch 17, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.